13.3 Radiation Burns, Cutaneous Radiation Syndrome, Cold Injuries (Frostbite Triage and Thawing Protocols), and Vasodilator Therapy

13.3 Radiation Burns, Cutaneous Radiation Syndrome, Cold Injuries (Frostbite Triage and Thawing Protocols), and Vasodilator Therapy

Core Knowledge: Cutaneous radiation syndrome (CRS) and cold injuries (frostbite) represent distinct physical trauma etiologies encountered in specialized burn intensive care units. Both entities share a common pathophysiological theme: delayed clinical manifestation of deep microvascular occlusion following an initial physical insult. Mastering the chronological stages of radiation injury, the biophysical principles of cellular freezing, evidence-based rapid rewarming protocols, and modern microvascular salvage therapies (tPA and prostacyclin analogues) is essential for the Certified Burn Registered Nurse.

---

1. Radiation Injuries and Cutaneous Radiation Syndrome (CRS)

Ionizing radiation (alpha particles, beta particles, gamma rays, and high-energy industrial X-rays) damages living tissue through the radiolysis of intracellular water, producing reactive oxygen species (ROS) that induce double-stranded DNA breaks. The most radiosensitive cells in the integumentary system are rapidly proliferating basal layer keratinocytes and microvascular endothelial cells.

               CUTANEOUS RADIATION SYNDROME (CRS) PHASES
  ┌────────────────────────────────────────────────────────────────────────┐
  │ 1. PRODROMAL PHASE (Hours to Days post-exposure):                      │
  │ • Transient erythema, warmth, pruritus, tingling, and localized edema. │
  │ • Driven by histamine, prostaglandin, and cytokine release.            │
  ├────────────────────────────────────────────────────────────────────────┤
  │ 2. LATENT PHASE (Days to several Weeks post-exposure):                 │
  │ • Asymptomatic 'quiescent' window; skin appears to recover.            │
  │ • Deceptive lull while progressive microvascular obliterative           │
  │   endarteritis and basal stem cell death progress unseen.              │
  ├────────────────────────────────────────────────────────────────────────┤
  │ 3. MANIFEST ILLNESS PHASE (Weeks to Months post-exposure):             │
  │ • Dose-dependent tissue breakdown:                                     │
  │   - Epilation / Hair Loss (>3 Gy)                                      │
  │   - Erythema & Dry Desquamation (>8–10 Gy)                             │
  │   - Moist Desquamation & Bullae (>12–15 Gy)                            │
  │   - Deep Ischemic Ulceration & Radionecrosis (>20–25 Gy)               │
  ├────────────────────────────────────────────────────────────────────────┤
  │ 4. LATE CHRONIC PHASE (Months to Years post-exposure):                 │
  │ • Dermal atrophy, dense subcutaneous fibrosis, telangiectasias,        │
  │   non-healing intractable ischemic ulcers, and secondary malignancies. │
  └────────────────────────────────────────────────────────────────────────┘

Clinical Management of Radiation Burns:

1. Decontamination: If external radionuclide contamination is present, patients must undergo thorough washing with warm water and mild soap; effluent water must be contained to prevent hazardous environmental spread.
2. Wound Care and Barrier Protection: Irradiated skin is prone to microvascular insufficiency and infection. Non-adherent silicone dressings, topical antimicrobials, and avoidance of mechanical trauma are essential.
3. Surgical Principles: Standard surgical debridement often fails in radiation wounds because surrounding tissue margins suffer from obliterative endarteritis with zero healing potential. Surgical reconstruction mandates wide radical excision back to well-vascularized tissue combined with vascularized free-tissue flap transfer or autologous stem-cell therapies.

---

2. Frostbite Pathophysiology: Cellular Freezing and Reperfusion Injury

Frostbite is a localized cold-induced injury characterized by tissue freezing. Its destructive process unfolds across two distinct pathophysiological phases:

                     BIPHASIC FROSTBITE PATHOPHYSIOLOGY
  ┌────────────────────────────────────────────────────────────────────────┐
  │ PHASE 1: DIRECT COLD-INDUCED CELLULAR DAMAGE (Freezing Phase)          │
  │ • Extracellular fluid freezes at -2°C (28.4°F), forming ice crystals.  │
  │ • Water shifts osmotically from inside cells to the extracellular space│
  │   causing severe cellular dehydration and hyperosmolality.             │
  │ • Intracellular ice crystals form mechanically, piercing and shearing  │
  │   plasma membranes and organelles, causing irreversible cell lysis.    │
  ├────────────────────────────────────────────────────────────────────────┤
  │ PHASE 2: PROGRESSIVE MICROVASCULAR THROMBOSIS (Reperfusion Phase)      │
  │ • Upon thawing, damaged vascular endothelial cells swell and release   │
  │   massive quantities of Thromboxane A₂ (TXA₂) and Prostaglandin F₂α.   │
  │ • Intense vasoconstriction, platelet aggregation, and leukocyte       │
  │   sludging generate progressive microthrombi in capillary beds.        │
  │ • Reperfusion reactive oxygen species (ROS) accelerate microvascular   │
  │   stasis, leading to progressive tissue ischemia and dry gangrene.     │
  └────────────────────────────────────────────────────────────────────────┘

---

3. Frostbite Classification and Staging

Frostbite is staged clinically into four degrees based on depth of freezing, blister characteristics, and sensory status following rewarming:

                    CLEAR VS. HEMORRHAGIC BLISTERS
  ┌────────────────────────────────────────────────────────────────────────┐
  │ • Clear / Milky Blisters (2nd Degree): Subepidermal cleavage above the │
  │   dermal vascular plexus; indicates underlying viable microvasculature.│
  │ • Hemorrhagic / Dark Blisters (3rd Degree): Subdermal cleavage below   │
  │   the vascular plexus; indicates deep microvascular thrombosis and     │
  │   dermal vascular bed necrosis.                                        │
  └────────────────────────────────────────────────────────────────────────┘

---

4. Evidence-Based Frostbite Rewarming Protocols

Proper pre-hospital and hospital rewarming protocols represent the single most important determinant of tissue preservation in cold injuries.

                   CARDINAL RULES OF FROSTBITE RESCUE
  ┌────────────────────────────────────────────────────────────────────────┐
  │ 1. NEVER THAW IF RISK OF REFREEZING EXISTS:                            │
  │    If a patient is in a wilderness/evacuation setting where refreezing  │
  │    is possible, DO NOT attempt to thaw. Walking on frozen feet causes   │
  │    far less tissue loss than walking on thawed, refrozen tissue.       │
  │    A freeze-thaw-refreeze cycle causes catastrophic, 100% tissue death.│
  ├────────────────────────────────────────────────────────────────────────┤
  │ 2. NEVER RUB OR MASSAGE FROZEN TISSUES:                                │
  │    Rubbing with snow or hands mechanically grinds internal ice crystals│
  │    against fragile cell membranes, lacerating microstructures.         │
  ├────────────────────────────────────────────────────────────────────────┤
  │ 3. NEVER USE DRY RADIANT HEAT:                                         │
  │    Campfires, car heaters, hair dryers, and hot water bottles cause    │
  │    severe thermal burns because the frostbitten skin is insensate.     │
  └────────────────────────────────────────────────────────────────────────┘

Standard Active Rapid Rewarming Protocol:

1. Circulating Water Bath: Immerse the affected extremity in a clean, circulating water bath maintained at precisely 37°C to 39°C (98.6°F to 102.2°F). Temperatures $>40^\circ\text{C}$ cause severe thermal burns to ischemic tissue, whereas temperatures $<37^\circ\text{C}$ delay rewarming and increase microvascular thrombosis.
2. Duration: Continue immersion for 15 to 30 minutes (or until the distal extremity becomes soft, pliable, and develops a deep red or purple erythematous flush).
3. Analgesia: Rapid active thawing produces excruciating, ischemic reperfusion pain. The nurse must proactively administer intravenous opioids (e.g., fentanyl, morphine) and scheduled NSAIDs (ibuprofen $400\text{--}800\text{ mg}$ to inhibit thromboxane $A_2$ synthesis).
4. Post-Thaw Care: Apply topical aloe vera cream (thromboxane inhibitor); dress digits individually with bulky, non-adherent sterile cotton gauze; elevate extremities above heart level to reduce edema; verify tetanus vaccination status.

---

5. Advanced Thrombolysis, Vasodilator Therapy, and Delayed Demarcation

Modern burn center protocols utilize advanced microvascular pharmacotherapy within the early therapeutic window to prevent digit and limb loss in deep frostbite (2nd–4th degree).

                     ADVANCED FROSTBITE SALVAGE MATRIX
  ┌────────────────────────────────────────────────────────────────────────┐
  │ THROMBOLYTIC THERAPY (tPA Protocol):                                   │
  │ • Therapeutic Window: Within 24 HOURS of rewarming.                    │
  │ • Indications: Severe frostbite with absent distal arterial flow on    │
  │   Doppler, angiography, or technetium-99m (Tc-99m) bone scintigraphy.  │
  │ • Agents: IV or catheter-directed intra-arterial (IA) tissue           │
  │   plasminogen activator (Alteplase) + continuous IV unfractionated     │
  │   heparin. Dissolves microvascular fibrin thrombi.                     │
  ├────────────────────────────────────────────────────────────────────────┤
  │ PROSTACYCLIN VASODILATOR THERAPY (Iloprost Protocol):                  │
  │ • Agent: Iloprost (prostacyclin analogue, PGI₂).                       │
  │ • Mechanism: Potent microvascular vasodilator; suppresses platelet    │
  │   aggregation and leukocyte adhesion; restores distal perfusion.       │
  │ • Regimen: Continuous IV infusion for 6 hours daily over 5–8 days.     │
  ├────────────────────────────────────────────────────────────────────────┤
  │ SURGICAL PRINCIPLE: DELAYED SURGICAL AMPUTATION                        │
  │ • Traditional Maxim: 'Freeze in January, amputate in July.'            │
  │ • Premature debridement or surgical amputation is strictly avoided.    │
  │ • Ischemic black eschars take 1 to 3 MONTHS to fully mummify and clear │
  │   demarcate; underlying viable dermis often regenerates beneath.       │
  │ • Emergent surgery is indicated ONLY for invasive wet gangrene/sepsis. │
  └────────────────────────────────────────────────────────────────────────┘